Innovation Pharmaceuticals Inc (IPIX)

[alwaysdreaming]

But my question, regardless of B, K, P, what risk is there to partner once a P3 for any drug has been completed? Yea for Big Pharma its a no brainer, but for us little guys we end up holding the bag if there's a glitch/clsn. Why shouldn't CTIX mitigate some of that risk now after a supposedly successful P2B trial by inking a deal, as opposed to going the "Pigs get Slaughtered" wait for a bigger payday deal?

At least for the steal of the decade, even if it's for 1 or 2 indications for that B platform?

Sorry, I want a not so instant gratification. I waited a whole year since we were to have P P2/3 data because of B. Time to make some Hay here, it's Harvest season...